| Literature DB >> 33207154 |
David Nguyen1, Nima Sarani1, Kenneth D Marshall1, Chad M Cannon1, Ryan C Jacobsen1, Andrew Pirotte1, Christine Pittenger1, Edric K Wong2, Nicholas P Dodson2, Maria LaCapra1, Kelly Howe1.
Abstract
Resuscitation of cardiac arrest in coronavirus disease 2019 (COVID-19) patients places the healthcare staff at higher risk of exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Unfortunately, COVID-19 status is unknown in most patients presenting to the emergency department (ED), and therefore special attention must be given to protect the healthcare staff along with the other patients. This is particularly true for out-of-hospital cardiac arrest patients who are transported to the ED. Based on the current data available on transmissibility of SARS-CoV-2, we have proposed a protocolized approach to out-of-hospital cardiac arrests to limit risk of transmission.Entities:
Mesh:
Year: 2020 PMID: 33207154 PMCID: PMC7673869 DOI: 10.5811/westjem.2020.7.48436
Source DB: PubMed Journal: West J Emerg Med ISSN: 1936-900X
Figure 1Illustrative diagram of code team and responsibilities to mitigate COVID-19 transmission.
Figure 2“Dump sheet” for cardiac arrest COVID-19 response.
Medications most commonly used in cardiac arrest resuscitation and a defibrillator are pre-positioned by the code team on a sheet. Its purpose is to avoid contaminating the crash cart.
Figure 3Cardiac arrest aerosol mitigation bag for cardiac arrest COVID-19 response.
This bag includes a supraglottic airway device, bag valve mask, viral filter, end tidal carbon dioxide monitoring adapter, and a plastic drape used to cover patient.
Figure 4Plastic drape for cardiac arrest COVID-19 response.
Used to cover patient during transport from ambulance bay to the resuscitation room. The drape has two vertical slits on top allowing the operator to access the airway and one horizontal slit below allowing for chest compressions or for further access as needed without having to remove the drape.